After having a heart attack in June 2018, my heart?s pumping capacity (LVEF) initially improved to 35% but has now dropped to 30% on an ultrasound and to 19% on a nuclear scan (MIBI) showing dead heart muscle and an enlarged heart chamber; what do these worsening results mean for my condition, and is my current medication list?including Ecosprin, Clopidogrel, Atorvastatin, Metoprolol XL, Fruselac, Glyceryl trinitrate, and Rabeprazole?still the right treatment plan for me?
The decline in your heart's pumping function (LVEF) to 30% on ultrasound and 19% on the nuclear scan suggests your heart muscle has weakened and enlarged due to scarring from your 2018 heart attack. Your current medications?including Ecosprin, clopidogrel, atorvastatin, metoprolol, and Fruselac?are standard, crucial therapies to protect your heart. However, with these new changes, your treatment plan needs a careful review. Please consult your cardiologist soon; they may optimize your dosages or introduce newer, highly effective medications to help strengthen your heart and improve your overall well-being.